The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction

NCT ID: NCT00616824

Last Updated: 2017-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to compare postoperative outcomes of a tissue expander placement following a mastectomy with two different operative techniques. This study will be randomized and double blinded comparing the traditional placement of the tissue expander under an inferolateral serratus muscle flap to a new technique which uses an acellular dermal matrix as an inferolateral sling, instead of the muscle flap.

The study we are proposing will evaluate the question of whether there is a difference between the traditional method of serratus flap and the new technique of using an acellular matrix with tissue expander placement. This will be a double blinded randomized study of thirty women in each group comparing outcomes which will include postoperative pain, complications (wound infection, hematoma, capsular contracture, etc), and patient satisfaction with the procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mastectomy Postoperative Pain Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Traditional Method

Arm which uses the Serratus Anterior muscle mobilization for lateral coverage of the tissue expander

Group Type ACTIVE_COMPARATOR

Serratus anterior to cover lateral aspect of tissue expander

Intervention Type PROCEDURE

Traditional use of serratus anterior for coverage of lateral aspect of tissue expander

Dermamatrix Arm

Arm which uses Dermamatrix as the lateral expander coverage

Group Type EXPERIMENTAL

Dermamatrix to cover lateral aspect of tissue expander

Intervention Type PROCEDURE

Dermamatrix used to cover lateral aspect of breast tissue expander after mastectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dermamatrix to cover lateral aspect of tissue expander

Dermamatrix used to cover lateral aspect of breast tissue expander after mastectomy

Intervention Type PROCEDURE

Serratus anterior to cover lateral aspect of tissue expander

Traditional use of serratus anterior for coverage of lateral aspect of tissue expander

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Dermamatrix

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients presenting to Dr. Wendel's clinic who are older than 17 years of age undergoing a mastectomy and wish to have breast reconstruction with a tissue expander or those who have previously undergone a mastectomy and are now seeking reconstruction will be solicited for the study.

Exclusion Criteria

* Preoperative radiation therapy
* Autoimmune disease
* Fever
* Uncontrolled diabetes mellitus
* Inability to comprehend or cooperate with postoperative instructions
* Local or systemic infection
* Have any allergies to the excipient ingredients found in the matrix
* Pregnancy
* Low vascularity of the surrounding tissue
* Mechanical trauma
* Poor nutrition
* Poor general medical condition
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vanderbilt University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jason J. Wendel, M.D.

Role: PRINCIPAL_INVESTIGATOR

Vanderbilt University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

070415

Identifier Type: -

Identifier Source: secondary_id

070415

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chronic Post Breast Surgery Pain
NCT00847067 TERMINATED NA